Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11207322
Method and composition related to combination therapy for addiction
granted -
US 11207329
Methods for treating GI syndrome and graft versus host disease
granted -
US 11208479
CX43 hemichannel antibodies and methods of use
granted -
US 11202808
Methods for treating autism spectrum disorder and associated symptoms
granted -
US 11203582
Benzamide derivatives for inhibiting endoplasmic reticulum (ER) stress
granted -
US 11203583
Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
granted -
US 11203618
Campylobacter immunogenic compositions and uses thereof
granted -
US 11197928
Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
granted -
US 11191778
Multifunctional linker technology containing an N4 group
granted -
US 11191750
Use of mTOR inhibitors for treatment of familial adenomatous polyposis
granted -
US 11192958
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
granted -
US 11185554
Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
granted -
US 11181520
Systems and methods for high-resolution imaging
granted -
US 11180452
Methods and compositions for selectively inhibiting pathogenic microbes
granted -
US 11180499
Phosphodiesterase inhibitors
granted -
US 11180765
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
granted -
US 11174495
Reporter system for detecting and targeting activated cells
granted -
US 11174291
Silstatin compounds
granted -
US 11174320
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted -
US 11173227
Wound dressings and applications thereof
granted -
US 11173145
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
granted -
US 11166949
NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic
granted -
US 11168325
Methods for treatment of polycystic kidney disease
granted -
US 11166962
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted